Covers the decline of cancer death rates, conventional and targeted anticancer drugs, surgical oncology, radiotherapy, chemotherapy, resistance mechanisms, and the history of targeted drugs and EGFR targeting.
Explores tumor immune evasion, drug delivery challenges, and nanoparticle strategies in cancer treatment, including the impact of checkpoint inhibitors and hydrogels.
Explores biology fundamentals, proteins, lipids, and DNA as synthetic materials, covering cell structure, membrane composition, protein production, DNA structure, and tissue engineering.
Explores the activation and differentiation of T lymphocytes, focusing on naive T cells recognizing antigens and differentiating into effector and memory cells.
